¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Blue Cross Assoc Res Ser"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • cross flap
    ±³Â÷ÇÇÆÇ
  • cross foot
    ¾ÈÂʹøÁü¹ß, ³»¹øÁ·
  • cross heredity
    ±³Â÷À¯Àü
  • cross immunity
    ±³Â÷¸é¿ª
  • cross infection
    ±³Â÷°¨¿°
  • cross inheritance
    ±³Â÷À¯Àü
  • cross neutralization
    ±³Â÷ÁßÈ­
  • cross reactivation
    ±³Â÷ÀçȰ¼ºÈ­
  • cross relaxation
    ±³Â÷ÀÌ¿Ï
  • cross section radiography
    ´ÜÃþ¹æ»ç¼±ÃÔ¿µ(¼ú)
  • cross sensitivity
    ±³Â÷¹Î°¨µµ
  • cross sensitization
    ±³Â÷¹Î°¨È­
  • cross striation
    °¡·Î¹«´Ì, Ⱦ¹®
  • cross training
    ±³Â÷ÈÆ·Ã
  • cross-antigenicity
    ±³Â÷Ç׿ø¼º
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • cross-leg
    Á¾¾Æ¸®±³Â÷-, ÇÏÅð±³Â÷-
  • cross-linking
    ±³Â÷°áÇÕ
  • cross-plate
    ±³Â÷ÆÇ
  • cross-protection
    ±³Â÷¹æ¾î
  • cross-reaction
    ±³Â÷¹ÝÀÀ
  • cross-reactivity
    ±³Â÷¹ÝÀÀ¼º
  • cross-resistance
    ±³Â÷ÀúÇ×
  • cross-section
    °¡·Î´Ü¸é
  • cross-talk
    ±³Â÷´ëÈ­
  • cross-tolerance
    ±³Â÷³»¼º
  • cross-validation
    ±³Â÷Ÿ´çµµ
  • criss-cross inheritance
    ½ÊÀÚÀ¯Àü, À̼ºÀ¯Àü
  • cross circulation
    ±³Â÷¼øÈ¯
  • cross cylinder
    ±³Â÷¿øÁÖ·»Áî
  • cross examination
    ±³Â÷°Ë»ç
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • blue rubber-bleb nevus syndrome
    û»ö°í¹«¼öÆ÷¸ð¹ÝÁõÈıº
  • blue rubber-bleb nevus syndrome
    û»ö°í¹«¼öÆ÷¸ð¹ÝÁõÈıº(ôìßä¡­â©øÜÙ½Úèñøý¦ÏØ)
  • blue sclera
    û»ö°ø¸·
  • blue spells
    û»öÁõ ¹ßÀÛ(¹«»ê¼Ò ¹ßÀÛ)(ôêßäñø Û¡íÂÙíß«áÈÛ¡íÂ).
  • blue tongue
    û¼³.
  • blue tongue virus
    û¼³(ôìàß)¹ÙÀÌ·¯½º
  • blue-field entopic phenomenon
    û»ö½Ã¾ß³»½ÃÇö»ó
  • blue<³ª> caeruleus
    û»ö(ôìßä)ÀÇ.
  • bromphenol blue
    ºê·ÒÆä³îºÒ·ç
  • bromthymol blue
    ºê·Ò½ÎÀ̸ôºÒ·ç
  • cellular blue nevus
    ¼¼Æ÷¼º û»ö¸ð¹Ý
  • common blue nevus
    º¸Åë û»ö ¸ð¹Ý
  • cyanobacter (blue-green algae)
    ³²Á¶·ù
  • diagnex blue test
    µð¾Æ±×³Ø½ºÃ»»ö½ÃÇè
  • drum, blue
    û»ö°í¸·
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • cross-reactivation
    ±³Â÷ÀçȰ¼ºÈ­(Îßó©î¢üÀàõûù)
  • cross-resistance
    ±³Â÷ÀúÇ×(Îßó©î½ù÷)
  • cross-sensitization
    ±³Â÷°¨ÀÛ(Îßó©ÊïíÂ)
  • cross-term diffusion coefficient
    ¹æÇØ È®»ê°è¼ö(Ûªúªüªß¤Íªâ¦)
  • cross tolerance
    ±³Â÷³»¼º(Îßó©Ò±àõ)
  • genetic cross
    À¯Àü ±³Â÷(ë¶îîÎßó©)
  • helical cross
    ³ª¼± ½ÊÀÚ(Õ¢àÁä¨í®)
  • phage cross
    ÆäÀÌÁö ±³Â÷(Îßó©)
  • photoactivated cross-linking
    ±¤ºÎȰ ±³Â÷ ¿¬°á(ÎÃÝ¥üÀÎßó©Ö§Ì¿)
  • three-factor cross
    »ïÀÎÀÚ ±³Â÷ (ß²ì×í­Îßó©)
  • three-point cross
    ¼¼Á¡ ±³Â÷(Îßó©)
  • two-factor cross
    ÀÌÀÎÀÚ ±³Â÷(ì£ì×í­Îßó©)
  • two-point cross
    ÀÌÁ¡±³Â÷(ì£ïÇÎßó©)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
res research; resection; resident; residue; resistance
BT base of tongue; bedtime; bitemporal; bitrochanteric; bladder tumor; Blalock-Taussig [shunt]; bleedin...
CB Bachelor of Surgery [Lat. Chirurgiae Baccalaureus]; calcium blocker; carbenicillin; carotid body; ch...
TB Taussig-Bind [syndrome]; terabyte; term birth; terminal bronchiole; terminal bronchus; thromboxane B...
SER   1) Smooth Endoplasmic Reticulum
  2) Sedimentation Erythrocyte Rate
&nbs...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
Ser/Thr Serine/threonine
SER Serotonin
SER Smooth Endoplasmic Reticulum
sER Smooth-surfaced endoplasmic reticulum
SER Somatosensory evoked response
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • cross contamination
    ±³Â÷ ¿À¿°
  • cross fire technique
    ½ÊÀÚÆ÷È­ Á¶»ç¹ý
  • cross heredity
    ±³Â÷ À¯Àü, ±³Â÷¼º À¯Àü
  • cross incision
    ½ÊÀÚ Àý°³
  • cross leg flap
    ÇÏÅð ±³Â÷ ÇÇÆÇ
  • cross linkage
    °¡±³È­
  • cross linking agent
    °¡±³Á¦
    ¼±»ó °íºÐÀÚÀÇ ºÐÀÚ°£À» È­ÇÐÀûÀ¸·Î °áÇÕÇϰí, ±×¹° ±¸Á¶¸¦ ¸¸µå´Â ÀÛ¿ëÀ» °®´Â ¹°Áú.
  • cross matching
    ±³Â÷ ½ÃÇè, ±³Â÷ ÀûÇÕ ½ÃÇè, ±³Â÷ ½ÃÇè¹ý, ±³Â÷ ÀûÇÕ ½ÃÇè¹ý
  • cross polymerization
    ±³Â÷ ÁßÇÕ
    ¼±»ó ÁßÇÕü ºÐÀÚ »çÀÌÀÇ È­ÇÐ °áÇÕ Çü¼ºÀº ±× ºÐÀÚµé·Î½á µÈ ¹«ÇÑ´ëÀÇ »ïÂ÷¿øÀû ¸Á»ó ±¸Á¶¿¡±îÁö À̸¦ ¼ö ÀÖ´Â ÁßÇÕ ¹ÝÀÀÀÌ´Ù. ±×·¡¼­ Àç·áÀÇ ¿ëÇØµµ, °­µµ, Èí¼ö¼ºÀ» ¹Ù²Ù´Â ÀÔüÀûÀÎ ¸Á»ó ±¸Á¶¸¦ Çü¼ºÇÏ°Ô µÈ´Ù.
  • cross reaction
    ±³Â÷ ¹ÝÀÀ
    Ç׿ø Ç×ü ¹ÝÀÀÀÇ °¡Àå Å« Ư¡Àº ÀÌ ¹ÝÀÀÀÌ Æ¯ÀÌÀûÀ̶ó´Â °ÍÀε¥ ¶§·Î´Â ÀÌ ¿øÄ¢¿¡ ¸ÂÁö ¾Ê´Â ¹ÝÀÀÀ» º¸ÀÌ°Ô µÇ´Â ¼ö°¡ ÀÖ´Ù. ¿¹¸¦ µé¾î ¼ÒÀÇ Ç÷û ¾ËºÎ¹Î¿¡ ´ëÇÑ Ç×ü´Â ¾çÀÇ Ç÷û ¾ËºÎ¹Î°úµµ ¾î´À Á¤µµ ¹ÝÀÀÇϴµ¥ ÀÌ °°Àº ¹ÝÀÀÀ» ±³Â÷ ¹ÝÀÀÀ̶ó ÇÑ´Ù.
  • cross relaxation
    ±³Â÷ ÀÌ¿Ï
  • cross section radiography
    Ⱦ´Ü ¹æ»ç¼± ÃÔ¿µ¼ú
  • cross sensitivity
    ±³Â÷ °ú¹Î ¹ÝÀÀ
  • cross striation
    °¡·Î¹«´Ì, Ⱦ¹®
  • cross tolerance
    ±³Â÷ ³»¼º
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
cross-reacting material <haematology> A substance sufficiently different from a reference substance (R) to have a perceptibly different function from R but sufficiently similar to R that it reacts with anti-R antibodies; e.g., mutant factor VIII may be defective or even inert in coagulation and yet be immunologically identified as factor VIII.
(05 Mar 2000)
cross reaction <haematology, immunology> Serological reactions in which an antiserum against one antigen reacts with a non-identical but closely related antigen.
(12 Dec 1998)
cross-reactive antibody <haematology, immunology> Antibodies which don't respond to any one specific antigen, but will respond to a number of them. These antibodies can be responsible for false positive results in antigen-antibody tests.
(09 Oct 1997)
cross-resistance <immunology, microbiology> Immunologic resistance to the pathogenic effects of a microorganism because of previous exposure to another species or type having cross reactive antigens.
This phenomenon is seen in microbes that acquire resistance to one drug through direct exposure and turn out to have resistance to one or more other drugs to which it has not been exposed. Cross-resistance arises because the mechanism of resistance to several drugs is the same and arises through the identical genetic mutations.
(09 Oct 1997)
cross-section <physics> Usually refers to the (apparent) area presented by a target particle to an oncoming particle (or electromagnetic wave). This measures the probability of an interaction occuring. For typical interactions between ions and electrons, or between two nuclei, these cross sections are generally measured in barns.
<anatomy> A transverse cut through a structure or tissue. The opposite of a cross-section is a longitudinal section. By analogy, a study may be cross-sectional or longitudinal.
(12 Dec 1998)
cross-sectional echocardiography two-dimensional echocardiography
cross-sectional method <epidemiology> The study of the life span involving comparison of groups of individuals at different age levels.
Compare: longitudinal method.
(05 Mar 2000)
cross-sectional study <epidemiology> A study in which the presence or absence of disease or other health-related variables are determined in each member of the study population or in a representative sample at one particular time. This contrasts with longitudinal studies which are followed over a period of time.
Synonym: horizontal study.
(18 Jul 2002)
cross-table lateral projection <radiology> Lateral projection radiography of a supine subject using a horizontal X-ray beam.
(05 Mar 2000)
cross tolerance <pharmacology> The resistance to one or several effects of a compound as a result of tolerance developed to a pharmacologically similar compound.
(05 Mar 2000)
section, cross A transverse cut through a structure. The opposite is a longitudinal section.
(12 Dec 1998)
holy cross The cross as the symbol of Christ's crucifixion. Congregation of the Holy Cross, a community of lay brothers and priests, in France and the United States, engaged chiefly in teaching and manual Labour. Originally called Brethren of St. Joseph. The Sisters of the Holy Cross engage in similar work. Holy-cross day, the fourteenth of September, observed as a church festival, in memory of the exaltation of our Savior's cross.
Source: Websters Dictionary
(01 Mar 1998)
study, cross-sectional A study done at one time, not over the course of time. A cross-sectional study a disease such as aids might be designed to learn its prevalence and distribution within the population at one point in time. Also known as a synchronic study.
(12 Dec 1998)
double back cross A mating that is a back cross at each of two loci of interest; of special value and importance in linkage analysis.
(05 Mar 2000)
International Committee of the Red Cross A neutral Swiss organization serving as an intermediary between contending forces in armed conflict, in civil war, or internal strife, to help victims receive protection and other humanitarian assistance under the Geneva Conventions in accordance with the fundamental principles of the Red Cross.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • blue scy law
    ºÎÁ¤ Áõ±Ç °Å·¡ ´Ü¼Ó¹ý 0
  • blue sky
    Ǫ¸¥ÇÏ´Ã
  • blue stread
    ¹ø°³;Àü±¤¼®È­(°°ÀÌ ºü¸¥°Í)
  • blue streak
    ¹ø°³;Àü±¤¼®
  • cobalt blue
    ÄÚ¹ßÆ® û»ö(¾È·á);¾Ïû»ö )
  • daylight blue
    ÁÖ±¤»ö;ÁÖ±¤»ö ä·á(¾È·á)
  • electic blue
    °­Ã»»ö(¹à°í ±Ý¼ÓÀûÀÎ(Â÷°¡¿î)´À³¦ÀÇ Ã»»ö)
  • indigo blue
    (È­)Àεð°í ÆÄ¶û;û¶÷»ö
  • methyl blue
    ¸Þƿû(û»öÀÇ À¯±â¿°·á,Çʱâ¿ë À×Å©³ª »ýü ¿°»ö¿¡ ¾¸)
  • natter blue
    ¿¯Àº û»ö
  • navy blue
    ¿µ±¹ ÇØ±ºÀÇ Á¦º¹»ö¿¡¼­ £Àº ³²»ö;³×À̺ñ ºí·ç;³×À̺ñ ºí·ç
  • navy blue
    £Àº ³²»öÀÇ
  • paris blue
    ÆÄ¸®ºí·ç;°¨Ã»
  • peacock blue
    ±¤Åà Àִ û»ö
  • pearl blue
    ¿¬ÇÑ È¸Ã»»ö
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á